FIELD: medicine, pharmaceutics.
SUBSTANCE: invention refers to biotechnology, particularly to a biologically active peptide. The peptide exhibits a modulating action on end-organs involved in nerve signal generation. The given peptide has an amino acid sequence: Gly1-Tyr2-Cys3-Ala4-Glu5-Lys6-Gly7-lle8-Arg9-Cys10-Asp11-Asp12-Ile13-His14-Cis16-Thr17-Gly18-Leu19-Lys20-Cys21-Lys22-Cys23-Asn24-Ala25-Ser26-Gly27-Tyr28-Asn29-Cys30-Val31-Cys32-Arg33-Lys34-Lys35.
EFFECT: invention can be used in medicine for studying the pain mechanisms, and also for detection and testing of new P2X3 receptor modulators.
7 dwg, 1 tbl, 7 ex
| Title | Year | Author | Number |
|---|---|---|---|
| PEPTIDE MODULATOR OF PURINERGIC RECEPTORS | 2016 |
|
RU2650780C1 |
| METHOD FOR OBTAINING RECOMBINANT ANALGESIC PEPTIDE | 2013 |
|
RU2571942C2 |
| METHOD OF PRODUCING A PEPTIDE WHICH MODULATES PURINERGIC RECEPTOR ACTIVITY | 2019 |
|
RU2714114C1 |
| ANALGESIC PEPTIDE OF SEA ANEMONE | 2016 |
|
RU2614759C1 |
| METHOD OF TREATMENT OF PERACUTE, CHRONIC AND SUBACUTE COUGH AND IRRESISTIBLE DESIRE TO CLEAR THROAT | 2014 |
|
RU2650118C2 |
| BENZIMIDAZOLE DERIVATIVES EFFECTIVE IN TREATING CONDITIONS ASSOCIATED WITH P2X3 AND P2X2/3 ACTIVITY | 2010 |
|
RU2542582C2 |
| ANALOGUE OF ALPHA-CONOTOXIN RGIA FOR TREATING PAIN | 2016 |
|
RU2731217C2 |
| RECOMBINANT PLASMID DNA PSMT3_HCRG21 ENCODING A HYBRID PROTEIN SMT3-HCRG21, BACTERIAL STRAIN ESCHERICHIA COLI BL21(DE3)/PSMT3_HCRG21 - PRODUCER OF HCRG21 ANALGESIC PEPTIDE AND METHOD OF PRODUCING RECOMBINANT HCRG21 ANALGESIC PEPTIDE | 2022 |
|
RU2798545C1 |
| PEPTIDE ANTAGONIST OF THE NMDA RECEPTOR | 2019 |
|
RU2716258C1 |
| METHOD OF TREATING INFLAMMATION IN NEURONAL TISSUE WITH USING MONOCLONAL ANTIBODY AND ITS BINDING FRAGMENT | 2007 |
|
RU2565391C2 |
